Literature DB >> 24493997

Patch test results in patients with allergic contact dermatitis in the Podlasie region.

Teresa Reduta1, Joanna Bacharewicz1, Anna Pawłoś1.   

Abstract

INTRODUCTION: The aim of the study was to provide current data on the incidence of allergy to various contact allergens in patients with allergic contact eczema and the analysis of selected socio-demographic data of the patients.
MATERIAL AND METHODS: The study included 1532 patients (1010 women and 522 men) treated for allergic contact dermatitis at the Department of Dermatology and Venereology and at the Dermatology Outpatient Clinic in Bialystok in 2007-2011. The assessment of selected demographic data and skin lesions was based on the MOAHFLA index, while the results of patch tests were analyzed with modified Baseline European Series consisting of 31 allergens.
RESULTS: In the group of patients with eczema, 34.1% were men, and 55% of all respondents were people over 40 years of age. The occupational character of skin lesions was found in 22.5%. Most frequently (38.9%) skin lesions were localized on the hands, rarely involved legs (3.98%). Atopic dermatitis was diagnosed in 4.5% of patients. The ten most frequent allergens were: nickel sulfate (24%), cobalt chloride (15.3%), fragrance mix (8.25%), potassium dichromate (6.8%), balsam of Peru (5.5%), neomycin (4.42%), paraphenylenediamine (3.85%), Quatermium-15 (2.1%), detreomycin (1.83%) and budesonide (1.44% of tested patients).
CONCLUSIONS: Frequent allergy to detreomycin indicates the need of patch testing for this allergen of all examined patients with allergic contact dermatitis. The increased frequency of the nickel allergy is a worrying problem and indicates the need for education about the risk factors for nickel allergy development and the implementation of appropriate legal regulations.

Entities:  

Keywords:  MOAHFLA index; allergic contact dermatitis; patch tests

Year:  2013        PMID: 24493997      PMCID: PMC3907899          DOI: 10.5114/pdia.2013.39433

Source DB:  PubMed          Journal:  Postepy Dermatol Alergol        ISSN: 1642-395X            Impact factor:   1.837


Introduction

Allergic contact dermatitis (ACD) is an inflammatory skin disorder resulting from the skin of allergic persons coming in contact with a small molecular weight chemical compound (hapten). The prevalence of this disease in the general population is evaluated in many countries and ranges from 15% [1] to 28% [2] and is increasing [3, 4]. The occurrence of an allergy to specific haptens in a given population depends on the sensitizing potency of the hapten and on the exposure of the skin to this chemical, which involves, inter alia, its prevalence in everyday life and occupational work environment [5]. In the past there were significant differences in the frequency of sensitization to particular allergens between different countries and regions of the world, but now, as a result of the overall process of globalization, gradual disappearance of these differences is observed. This is reflected in the development of a common set of contact allergens for many countries by international bodies. These series of allergens are regularly updated according to the results obtained in different research centers [6-8]. However, literary data indicate a number of variations between different countries, between regions within the same country [9, 10] and time variability of the results observed in the same research center [11, 12].

Aim

The aim of the study was to provide current data on the frequency of sensitization to various contact allergens in patients with allergic contact dermatitis and the analysis of selected socio-demographic and clinical data of the patients.

Material and methods

The study included 1532 adult patients with suspected allergic contact dermatitis, treated at the Department of Dermatology and Venereology of the Medical University of Bialystok and at the Dermatology Outpatient Clinic of the Regional Specialist Hospital in Bialystok in 2007–2011. The assessment of selected demographic and clinical data was based on the MOAHFLA (male, occupational dermatitis, atopic dermatitis, hand, face, leg, age > 40) index. The following factors were considered: sex, age, location of primary lesions, occurrence of atopic dermatitis, and the relationship between the development of skin lesions and occupational work. The association of the development of skin lesions with occupational work was established on the basis of a detailed history, clinical picture of skin lesions and patch test results. These data were calculated for the entire study group as well as for men and women separately (Table 1).
Table 1

Demographic and clinical data of patients with allergic contact dermatitis considering the MOAHFLA index

GenderFemalesMalesTotal
n % n % n %
M(ale)101065.952234.11532
O(ccupational)18818.6515830.334622.5
A(topic dermatitis)535.2173.3694.5
H(and)37136.722543.159638.9
F(ace)15114.95346.518512.07
L(eg)333.3285.4613.98
A(ge) [years] Mean Range > 4042.7 ±15.02(18–88)54253.745.5 ±15.9(18–85)30157.743.6 ±15.5(18–88)84355.02
Positive results60760.122142.382854.04

n – number of tested patients

Demographic and clinical data of patients with allergic contact dermatitis considering the MOAHFLA index n – number of tested patients Patch tests were set up for 48 h with a set of 31 allergens, containing an extended standard series of contact allergens which have been used for many years in Poland (F.P. Test Epidermal, E. Jaworski, Katowice, Poland) supplemented by other allergens included in the Baseline Standard Series (Chemotechnique Diagnostics, Sweden) (Table 2). The patch test results were read after 48 h and 96 h, and were evaluated according to the International Contact Dermatitis Research Group, ICDRG [13].
Table 2

The series of allergens used for patch testing

No.SubstanceConcentrationVehicle
1Nickel sulfate1 5Petrolatum
2Cobalt chloride1 1Petrolatum
3Potassium dichromate1 0.5Petrolatum
4Mercury chloride1 0.03Water
5Neomycin sulfate1 20Petrolatum
6Fragrance mix2 8Petrolatum
7Balsam of Peru1 25Petrolatum
8Thiuram1 1Petrolatum
9Colophonium1 20Petrolatum
10p-Phenylenediamine (PFD)1 1Petrolatum
11N-isopropyl-N’-phenyl-p-phenylenediamine (IPPD)1 0.15Petrolatum
12Paraben mix1 9Petrolatum
13Methyldibromoglutaronitrile (MBGN)2 0.5Petrolatum
14Benzocaine/caine mix2 5Petrolatum
15Sesquiterpene lactone mix, Lactone mix2 0.1Petrolatum
16Budesonide2 0.01Petrolatum
17Lanolin alcohol1 30Petrolatum
18Detreomycin1 2Petrolatum
19Epoxy resin1 1Petrolatum
204-tert-butylphenol formaldehyde resin2 1Petrolatum
21Mercaptobenzothiazole1 2Petrolatum
22Quatermium-152 1Petrolatum
23Salicylic acid3 5Petrolatum
24Rivanol3 1Petrolatum
252-metoksy-6-n-pentylo-4-benzochinon, Primin2 0.01Petrolatum
26Methylchloroisothiazolinone/Methylisothiazolinone (MCI/MI), Kathon CG2 0.01Water
27Tixocortol-21-pivalate2 0.1Petrolatum
28Clioquinol2 5Petrolatum
29Hydroxyizohexyl-3-cyclohexene-carboxaldehyde, Lyral2 5Petrolatum
30Turpentine1 10Rapeseed oil
31Formaldehyde1 0.7Water

F.P Testów naskórkowych, E. Jaworski, Katowice, Poland

Chemotechnique Diagnostics, Sweden

Additional allergens

The series of allergens used for patch testing F.P Testów naskórkowych, E. Jaworski, Katowice, Poland Chemotechnique Diagnostics, Sweden Additional allergens

Results

The specific demographic and clinical data, taking into consideration the MOAHFLA index, are presented in Table 1. Of the total 1532 ACD patients, 1010 (65.9%) were women and 522 (34.1%) were men. The mean age was 43.6 ±15.5 (range: 18–88) years, the proportion of patients above 40 years of age was 55% of all patients. The occupational character of skin lesions was found in 246 people (22.5%), with a similar incidence in both sexes, 188 women (12.2%) and 158 men (10.3%). The most frequent localization (seen in 596 (38.9%) patients) of the eczematous lesions were hands. Facial eczema was detected in 185 (12.07%) patients. Rarely (in 61 (3.98%) patients) eczematous lesions were observed on legs. Facial eczema affected 151 (9.86%) women and 34 (2.21%) men, hand eczema was found in 371 women (24.2%) and 225 men (14.7%). However, leg dermatitis was detected in 33 (2.15%) women and 28 (1.83%) men. Atopic dermatitis was found in 69 (4.5%) patients. Positive patch test results with at least one allergen were obtained for 828 (54%) patients, more frequently in men than in women (60.1% vs. 42.3%). The frequency of sensitization to allergens used for the study is shown in Table 3. Positive reactions were observed most commonly for nickel sulfate (24%), cobalt chloride (15.3%), fragrance mix (8.25%), potassium dichromate (6.8%), balsam of Peru (5.5%), neomycin sulfate (4.42%), p-Phenylenediamine (3.85%). Less common were: Quatermium-15 (2.1%), detreomycine (1.83%), budesonide (1.44%), colophonium (1.4%), tixocortol pivalate (1.37%), 4-tert-butylphenol formaldehyde resin (1.3%), thiuram (1.24%), benzocaine/caine mix (1.12%). An allergy to: paraben mix (0.84%), mercaptobenzothiazole (0.72%), primin (0.7%), N-isopropyl-N’-phenyl-p-phenylenediamine (0.65%), rivanol (0.54%), epoxy resin (0.46%), formaldehyde (0.4%), mercury chloride (0.4%), methyldibromo glutaronitrile (0.36%), turpentine (0.32%), methylchloroisothiazolinone/methylisothiazolinone (0.32%), lactone mix (0.32%), clioquinol (0.27%) and salicylic acid (0.26%) was rarely detected.
Table 3

Positive patch test results with contact allergens in patients with allergic contact dermatitis

No.AllergenNumber of tested patients (female/male)Number of positive resultsValue of p
Total n (%)Female n (%)Male n (%)
1Nickel sulfate1532 (1010/522)368 (24)334 (33.1)34 (6.51)< 0.0001#
2Cobalt chloride1532 (1010/522)240 (15.3)186 (18.4)54 (10.3)< 0.001#
3Fragrance mix1532 (1010/522)125 (8.3)86 (8.5)39 (7.5)0.49
4Potassium dichromate1532 (1010/522)105 (6.8)62 (6.1)43 (8.2)0.12
5Balsam of Peru1532 (1010/522)85 (5.5)58 (5.7)27 (5.1)0.4
6Neomycin sulfate1532 (1010/522)69 (4.42)38 (3.7)31 (5.9)< 0.05#
7PFD1532 (1010/522)59 (3.85)41 (4.1)18 (3.4)0.5
8Quatermium-15713 (468/245)15 (2.1)11 (2.35)4 (1.6)0.5
9Detreomycin1532 (1010/522)28 (1.83)14 (1.4)10 (1.9)0.45
10Budesonide1532 (1010/522)22 (1.44)12 (1.2)10 (1.9)0.27
11Colophonium1532 (1010/522)22 (1.4)18 (1.8)4 (0.77)< 0.01#
12Tixocortol-21-pivalate267 (160/107)4 (1.37)1 (0.6)3 (2.8)0.22
134-tert-butylphenol formaldehyde resin1251 (815/436)16 (1.3)6 (0.7)10 (2.3)< 0.05#
14Thiuram1532 (1010/522)19 (1.24)9 (0.9)10 (1.9)< 0.001#
15Benzocaine/Caine mix1110 (716/394)17 (1.12)12 (1.7)5 (1.3)0.54
16Lanolin alcohol1532 (1010/522)14 (0.91)8 (0.8)6 (1.15)0.49
17Paraben mix1532 (1010/522)13 (0.84)12 (1.2)1 (0.1)< 0.05#
18Mercaptobenzothiazole1532 (1010/522)11 (0.72)4 (0.4)7 (1.34)< 0.05#
19Primin291 (174/117)2 (0.7)2 (1.15)00.24
20IPPD1532 (1010/522)10 (0.65)6 (0.6)4 (0.77)0.69
21Rivanol1532 (1010/522)7 (0.54)5 (0.49)2 (0.13)0.2
22Epoxy resin1532 (1010/522)7 (0.46)4 (0.4)3 (0.6)0.58
23Mercury chloride1532 (1010/522)6 (0.4)3 (0.3)3 (0.6)0.78
24Formaldehyde1532 (1010/522)6 (0.4)4 (0.4)2 (0.13)0.36
25Methyldibromo glutaronitrile1110 (716/394)4 (0.36)2 (0.3)2 (0.4)0.78
26Lactone mix1532 (1010/522)5 (0.32)4 (0.4)1 (0.1)0.3
27CMI/MI1532 (1010/522)5 (0.32)5 (0.5)00.1
28Turpentine1532 (1010/522)5 (0.32)5 (0.5)00.1
29Clioquinol1487 (979/508)4 (0.27)3 (0.3)1 (0.2)0.72
30Lyral1532 (1010/522)4 (0.27)1 (0.1)3 (0.57)< 0.001#
31Salicylic acid1532 (1010/522)4 (0.26)2 (0.2)2 (0.38)0.5

Statistically significant, p < 0.05

Positive patch test results with contact allergens in patients with allergic contact dermatitis Statistically significant, p < 0.05

Discussion

The analysis of the demographic data of examined eczema patients in Bialystok showed strong similarities in terms of age and sex to the population of patients with eczema evaluated in other countries. As in most other countries, we observed almost double the number of women among eczema patients (percentage of men 34.1%). Fifty-five percent of people examined were above 40 years old, which was similar to other groups of eczema patients [9, 10, 14]. Among the patients of the clinic in Bialystok, the occupational character of skin lesions was observed in 22.5% of people, significantly more often in men. Based on the available literary data, the occupational nature of allergic contact dermatitis has been reported in a wide range: from 4.1% to 55%, depending on the health center, more often in centers specializing in occupational diseases, where patients with a specific profile register [9, 15]. Atopic dermatitis was observed in 4.5% of patients with contact dermatitis. The percentage is lower in comparison with results from other countries, where the atopic dermatitis was seen in 6.9% to 37% of respondents. The explanation for these differences may be that in our study we included only adults, in contrast to other centers, where children were also evaluated. Another reason may be a lower incidence of atopic dermatitis in Poland [16]. The most common primary location of eczematous lesions was the hands (38.9%). Hand eczema prevailed among men. The percentage of patients with hand dermatitis was similar to that in other countries [9] but lower than in the occupational disease centers in Finland and Poland [9, 15]. The second most common location of lesions was the face (12.1% of patients), more than twice as often in women than men (14.95% vs. 6.5%). Surprising is the small percentage of patients with leg eczema (3.98%), since in this group contact allergy is developed by most patients. The explanation of this may be the rarity of patients with leg ulcers being hospitalized by our department, which means that these patients are not diagnosed for contact allergy. In other European countries, patients with leg eczema were observed with various frequency varying from 3.3% in the UK to 17.5% in Denmark, and only 1.4% of the tested patients with eczema at the Centre of Occupational Diseases in Finland. The frequency of positive patch test results in the patients (54%) as well as a clear predominance of women among applicants with eczema, are within the range of results available in the literature, domestic and foreign [2, 9, 15]. Most positive patch tests in the study group were obtained for nickel sulfate (24% of the tested). This value is similar to the results from the Institute of Occupational Medicine in Lodz [15] and most European countries [9], with the exception of Denmark, Germany and Sweden, where a significant decrease in allergy to this metal has been observed in recent years [17-21]. In 1990, Denmark introduced a legal regulation limiting the concentration of nickel in objects which come in direct contact with the skin [22], and in 2001, the so-called European Nickel Directive legislation was introduced all across the European Union [23]. Compared with previous studies, the percentage of people allergic to nickel has increased in our center over the last 10 years (from 17%) [24], despite the “nickel directive” – in force since 2005. An increase in allergies to nickel has recently been observed in the United States and other countries where there are no regulations limiting exposure to the metal [25, 26]. Allergy to nickel is observed significantly more often among women (visible in our patients), which is explained by early exposure to allergens contained in jewelry, especially earrings. The second most frequent allergen detected among patients was cobalt chloride. Positive reactions to this allergen occurred in 15.3% of people tested, and this percentage was greater than in other European countries [9]. Most patients with positive cobalt tests also had allergies to nickel and chromium, and it was significantly more frequent, especially in the case of nickel, among women. Fragrances evoked positive reactions in 8.25% of patients, ranking the third. This is similar in proportion to the results found in many other European countries, but higher than the results from Spain (3.8%) and lower than in Germany (12.4%), the Netherlands (12.8%), Belgium (11.2%) and Denmark (11%) [14, 27]. When compared with a period of 10 years ago in Bialystok, there has been a slight increase in allergies to fragrances, which seems to reflect a general trend [27]. Positive test results occurred slightly more often among women, but the difference was not statistically significant. The sources of allergies to fragrances are mostly cosmetics but the allergy may also develop through occupational conditions. Balsam of Peru has been an important contact allergen since the first set of allergens was developed in 1969. It is considered an indicator of allergies to fragrances, detecting about 50% of allergies to this group of allergens [28, 29]. Among our patients positive patch tests with balsam of Peru were found in 5.5% of patients. Balsam is a substance which is derived from the Myroxolon balsamum tree, contains a number of allergenic compounds that are added to food fragrances and flavorings, which also cause cross-reactions with many products of plant origin, such as colophony, turpentine and wood tar. Positive test results to potassium dichromate were found in 6.8% of patients and were similar to those observed 10 years ago. This is a slightly lower percentage compared with the results of the Nofer Institute in Lodz (9.5%), but similar to those observed in Sweden and Portugal [14]. A surprising phenomenon was that no significant difference in the occurrence of positive results for chromium was observed among our patients between men and women. Until now, the allergy to chromium concerned mainly men and often had an occupational character, which in the past was also observed in the Bialystok clinic. Currently, the source of this allergy has become contact with leather items [30], which may to some extent explain the change observed in the sex ratio. Neomycin held a high position (4.4% of positive reactions) among the most common contact allergens in the patients examined, however the percentage of positive results for this allergen has decreased by half in our center over the past 10 years. The reason for this decline is probably a significantly lower representation of patients with leg ulcers among whom the allergy to neomycin is particularly common and which affects about one third of patients [29, 31]. It is also assumed that the high prevalence of sensitization caused less frequent use of the antibiotic by dermatologists. The percentage of patients who are allergic to neomycin in the entire study group is slightly higher compared to the data from most other European countries, with the exception of Finland, where positive tests with this antibiotic are observed in up to 7.7% of tested patients [14]. Significantly more positive results with neomycin were reported among men. In our group of ACD patients p-phenylenediamine was the cause of positive reactions in 3.85%, which is in the range of results from other studies in Poland and abroad [14, 15]. Previous studies in Bialystok showed that the allergy to PFD was found significantly more often among women, but currently this difference does not show signs of significance. Paraphenylenediamine is the aromatic amine present in commonly used hair and clothing dyes and in pigments for tattoos. The fashion for hair coloring in young women and girls, as well as the popularity of temporary and permanent tattoos have resulted in a significant increase in the allergy to this substance. Paraphenylenediamine is a potent contact allergen that can also cause very serious allergic reactions of immediate type [32] and in rare cases, the intravascular hemolysis leading to renal failure [33]. The allergy to PFD is also clinically important due to the possibility of cross reactions with many other substances from the so-called para group such as: pigments of many hair and clothing dyes, components of rubber, epoxy resins, local anesthetics and sulfonamides. The positive phenomenon seen in our ACD patients is the almost twofold decrease in the frequency of positive patch test results for PFD over the past 10 years. This is probably caused by the decreased content of this substance in hair dyes. Positive tests for Quatermium-15 occurred in 2.1% of ACD patients which placed this allergen in the ninth position on the list of allergens. In other European countries the percentage of positive results for this allergen varies between 0.7% and 2.7% [14]. Quatermium-15, or Dowicil 200, is the most frequently sensitizing substance among formaldehyde-releasing preservatives included in many cosmetics, hygiene care products and cleaning agents, but the allergy may also develop through occupational conditions [34]. Positive reactions to Quatermium-15 are accompanied by more than 50% of reactions to formaldehyde [35], but in our patients, the percentage was lower, which probably depended on the lower concentration used as the patch testing substance. Ten most frequent allergens in patients tested in our department included also detreomycin, giving positive patch test reactions in 1.83% of patients examined, with equal frequency in women and in men. This percentage is similar to the results of a former study performed in Bialystok [24]. Detreomycin is not included in the European baseline standard series, but is used in the treatment of skin diseases both in humans and animals. It is for this reason that we still routinely perform patch tests with this allergen. An allergy to budesonide occurred in 1.44% of patients and slightly less frequently to tixocortol-21-pivalate (1.37% of patients tested). Together, both corticosteroids caused positive reactions in 2.81% of ACD patients, which makes them an important group of contact allergens. The percentage of reactions to budesonide is within the range of results obtained in other European centers, varying from 0.1% to 2.3% of tested patients, similarly to reactions to tixocortol-21-pivalate which varies from 0.7% to 3% [14]. Less frequent (0.7%) allergy to both corticosteroids was noted in Sweden (Malmo), while the most frequent (6.2%) positive reactions were obtained in Germany (Dortmund) [14]. Reaction to budesonide is a good marker for the detection of an allergy to many topical fluorinated corticosteroids from group B, whereas tixocortol-21-pivalate detects hypersensitivity to hydrocortisone derivates from group A according to Coopman's classification [36]. Corticosteroids included in this patch test series may also detect an allergy to substances from group D due to the possibility of cross reactions. Quite frequently (above 1% of those tested) positive results were obtained for colophony, formaldehyde, resins, thiuram and benzocaine. An allergy to colophony (1.4%) is at present seen in our department less frequently than 10 years ago (3.8%) and also in other European countries, where it varies between 1.9% and 5.2% [14]. Formaldehyde resins caused positive reactions in 1.3% of ACD patients, which was similar to those in Belgium (1.4%) and Germany (1.5%) but less frequent than in Spain (3%), Finland (4.3%) and Denmark (3.2%) [10, 14]. An allergy to thiuram currently affects 1.4% of the contact eczema patients in our department, which is comparable with results from Sweden. In the past, hypersensitivity to thiuram was twice as frequent and similar to data from most other European centers. Very similar test results were obtained with benzocaine. Positive reactions to this allergen were seen slightly less frequently than in other countries and than in our department 10 years ago [24]. Comparing our results to the data from the Nofer Institute in Lodz, similar frequency of positive reactions was obtained with nickel sulfate, cobalt chloride and Balsam of Peru. Formaldehyde, turpentine, benzocaine, thiuram and mercaptobenzothiazole included in the list of the ten most frequent allergens in Lodz were not present in our results. Instead, we observed fragrances, neomycin, detreomycin, budesonide and Quatermium-15. The explanation to these differences may be that the majority of patients in Lodz had occupational contact eczema, whereas in Bialystok all ACD patients were examined. Our patients showed a low incidence of hypersensitivity to preservatives included in a series of allergens used for testing: clioquinol, methylobromoglutaronitrile, Kathon CG and formaldehyde. These results are very similar to the data from Spain [10]. The exception in our patients was the Quatermium-15 and paraben mix, which caused positive patch test reactions in more than 1% of tested patients, similarly to the results from Germany. In other European countries, the frequency of allergy to these 2 substances was lower, but it was higher for the remaining preservatives [14, 37, 38]. Few positive reactions (0.32%) were noticed with sesquiterpene lactones, the only plant allergen used in the series of tested substances. Reactions to this allergen concerned almost entirely farmers (data not shown). Higher percentages were seen in other regions of Europe [9]. Allergy to methylobromodiglutaronitrile varied within a broad range: from 0–0.3% in Southern Europe to 5.6% in Central Europe [9]. The current patch test results for consecutive adult patients with allergic contact dermatitis have been presented. The proportion of women and men, as well as the distribution of the age groups, are similar to most of those observed in analogous eczema patients groups from other European countries. However, remarkable differences have been noticed in the other characteristics from the MOAHFLA index: incidence of atopic dermatitis, occupational character of eczema and localization of skin lesions. Unlike in other European countries, among 10 most frequently sensitizing allergens some were not present in patients examined in Bialystok, such as: thiuram, formaldehyde and most of frequently used preservatives. Detreomycin, which is not included in the baseline series of allergens, was, however, still present. The high incidence of hypersensitivity indicates the need for testing of all eczema patients for this antibiotic. The decline of allergy to neomycin, paraphenylenediamine, thiuram is beneficial. The increase in the frequency of the allergy to nickel is a worrying problem, which indicates the need for education about the risk factors for nickel allergy development and for the implementation of the appropriate legal regulations.
  29 in total

1.  Monitoring the European standard series in 10 centres 1996-2000.

Authors:  D P Bruynzeel; T L Diepgen; K E Andersen; F M Brandão; M Bruze; P J Frosch; A Goossens; A Lahti; V Mahler; H I Maibach; T Menné; J D Wilkinson
Journal:  Contact Dermatitis       Date:  2005-09       Impact factor: 6.600

2.  Contact sensitivity to preservatives in the UK, 2004-2005: results of multicentre study.

Authors:  Cherng T Jong; Barry N Statham; Cathy M Green; Codagh M King; David J Gawkrodger; Jane E Sansom; John S C English; S Mark Wilkinson; Anthony D Ormerod; Mahbub M U Chowdhury
Journal:  Contact Dermatitis       Date:  2007-09       Impact factor: 6.600

3.  Relationship between formaldehyde and quaternium-15 contact allergy. Influence of strength of patch test reactions.

Authors:  Anton C de Groot; Janine Blok; Pieter-Jan Coenraads
Journal:  Contact Dermatitis       Date:  2010-10       Impact factor: 6.600

4.  Preservation of products with MCI/MI in Switzerland.

Authors:  E Reinhard; R Waeber; M Niederer; T Maurer; P Maly; S Scherer
Journal:  Contact Dermatitis       Date:  2001-11       Impact factor: 6.600

5.  Contact sensitization to metals in Taiwan.

Authors:  Teh-Yang Cheng; Yu-Hsian Tseng; Chee-Ching Sun; Chia-Yu Chu
Journal:  Contact Dermatitis       Date:  2008-12       Impact factor: 6.600

6.  55 cases of allergic reactions to hair dye: a descriptive, consumer complaint-based study.

Authors:  H Søsted; T Agner; K E Andersen; T Menné
Journal:  Contact Dermatitis       Date:  2002-11       Impact factor: 6.600

7.  Detection of nickel sensitivity has increased in North American patch-test patients.

Authors:  Robert L Rietschel; Joseph F Fowler; Erin M Warshaw; Donald Belsito; Vincent A DeLeo; Howard I Maibach; James G Marks; C G Toby Mathias; Melanie Pratt; Denis Sasseville; Frances J Storrs; James S Taylor; Kathryn A Zug
Journal:  Dermatitis       Date:  2008 Jan-Feb       Impact factor: 4.845

8.  Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids.

Authors:  S Coopman; H Degreef; A Dooms-Goossens
Journal:  Br J Dermatol       Date:  1989-07       Impact factor: 9.302

9.  Allergic contact dermatitis from cosmetics. Retrospective analysis of 819 patch-tested patients.

Authors:  L Kohl; A Blondeel; M Song
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

10.  Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991-2000).

Authors:  J D Wilkinson; S Shaw; K E Andersen; F M Brandao; D P Bruynzeel; M Bruze; J M G Camarasa; T L Diepgen; G Ducombs; P J Frosch; A Goossens; J-M Lachappelle; A Lahti; T Menné; S Seidenari; A Tosti; J E Wahlberg
Journal:  Contact Dermatitis       Date:  2002-04       Impact factor: 6.600

View more
  6 in total

1.  Analysis of skin patch test results and metalloproteinase-2 levels in a patient with contact dermatitis.

Authors:  Milena Wojciechowska; Rafał Czajkowski; Bogna Kowaliszyn; Magdalena Żbikowska-Gotz; Zbigniew Bartuzi
Journal:  Postepy Dermatol Alergol       Date:  2015-06-10       Impact factor: 1.837

2.  Analysis of Epicutaneous Patch Test Results in Patients with Contact Dermatitis.

Authors:  Emina Kasumagic-Halilovic; Nermina Ovcina-Kurtovic
Journal:  Med Arch       Date:  2018-10

Review 3.  Metal allergy after the Nuss procedure for pectus excavatum: a review.

Authors:  Przemysław Gałązka; Kamil Leis; Kacper Kroczek; Aleksandra Baska; Jakub Kazik; Rafał Czajkowski
Journal:  Postepy Dermatol Alergol       Date:  2021-01-06       Impact factor: 1.837

4.  The prevalence of contact hypersensitivity in patients with oral lichen planus.

Authors:  Maria Olejnik; Dorota Jenerowicz; Zygmunt Adamski; Magdalena Czarnecka-Operacz; Barbara Dorocka-Bobkowska
Journal:  Postepy Dermatol Alergol       Date:  2021-10-25       Impact factor: 1.664

5.  Prevalence of contact allergy to corticosteroids in a Danish patient population.

Authors:  Sebastian Vigand Svendsen; Rasmus Overgaard Bach; Charlotte G Mortz
Journal:  Contact Dermatitis       Date:  2022-05-26       Impact factor: 6.419

6.  Contact allergy in the population of patients with chronic inflammatory dermatoses and contact hypersensitivity to corticosteroids.

Authors:  Marek Kot; Jarosław Bogaczewicz; Beata Kręcisz; Anna Woźniacka
Journal:  Postepy Dermatol Alergol       Date:  2017-05-29       Impact factor: 1.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.